Plasma membrane localization of the μ-opioid receptor controls spatiotemporal signaling

Science Signaling

Volumn 9, Issue 414, 2016, Pages

  Halls, Michelle L ^a   Yeatman, Holly R ^a   Nowell, Cameron J ^a   Thompson, Georgina L ^a   Gondin, Arisbel Batista ^a   Civciristov, Srgjan ^a   Bunnett, Nigel W ^a,b   Lambert, Nevin A ^c   Poole, Daniel P ^a,b   Canals, Meritxell ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; G BETA GAMMA COMPLEX; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; MU OPIATE RECEPTOR; PROTEIN KINASE C; UNCLASSIFIED DRUG; NARCOTIC ANALGESIC AGENT;

ANIMAL CELL; ARTICLE; BIOPHYSICS; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CELL NUCLEUS; COMPLEX FORMATION; CONTROLLED STUDY; CYTOSOL; DORSAL ROOT; ENZYME ACTIVITY; GANGLION; HEK293 CELL LINE; HUMAN; HUMAN CELL; INTERNALIZATION; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; AGONISTS; DRUG EFFECTS; GENETICS; METABOLISM;

ANALGESICS, OPIOID; CELL MEMBRANE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; HEK293 CELLS; HUMANS; MORPHINE; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION;

EID: 84958531919     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aac9177     Document Type: Article

References (66)

1. N. G. Tsvetanova, M. von Zastrow, Spatial encoding of cyclic AMP signaling specificity by GPCR endocytosis. Nat. Chem. Biol. 10, 1061-1065 (2014).
2. D. Calebiro, V. O. Nikolaev, M. C. Gagliani, T. de Filippis, C. Dees, C. Tacchetti, L. Persani, M. J. Lohse, Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. PLOS Biol. 7, e1000172 (2009).
3. V. O. Nikolaev, M. Bünemann, E. Schmitteckert, M. J. Lohse, S. Engelhardt, Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching β1-adrenergic but locally confined β2-adrenergic receptor-mediated signaling. Circ. Res. 99, 1084-1091 (2006).
4. K. Ahlbeck, Opioids: A two-faced Janus. Curr. Med. Res. Opin. 27, 439-448 (2011).
5. R. Al-Hasani, M. R. Bruchas, Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology 115, 1363-1381 (2011).
6. J. L. Whistler, M. von Zastrow, Morphine-activated opioid receptors elude desensitization by β-arrestin. Proc. Natl. Acad. Sci. U.S.A. 95, 9914-9919 (1998).
7. J. Zhang, S. S. G. Ferguson, L. S. Barak, S. R. Bodduluri, S. A. Laporte, P.-Y. Law, M. G. Caron, Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness. Proc. Natl. Acad. Sci. U.S.A. 95, 7157-7162 (1998).
8. N. Quillinan, E. K. Lau, M. Virk, M. von Zastrow, J. T. Williams, Recovery from μ-opioid receptor desensitization after chronic treatment with morphine and methadone. J. Neurosci. 31, 4434-4443 (2011).
9. S. Just, S. Illing, M. Trester-Zedlitz, E. K. Lau, S. J. Kotowski, E. Miess, A. Mann, C. Doll, J. C. Trinidad, A. L. Burlingame, M. von Zastrow, S. Schulz, Differentiation of opioid drug effects by hierarchical multi-site phosphorylation. Mol. Pharmacol. 83, 633-639 (2013).
10. D. E. Keith, S. R. Murray, P. A. Zaki, P. C. Chu, D. V. Lissin, L. Kang, C. J. Evans, M. von Zastrow, Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271, 19021-19024 (1996).
11. L. M. Bohn, R. J. Lefkowitz, R. R. Gainetdinov, K. Peppel, M. G. Caron, F.-T. Lin, Enhanced morphine analgesia in mice lacking β-arrestin 2. Science 286, 2495-2498 (1999).
12. C. E. Groer, K. Tidgewell, R. A. Moyer, W. W. Harding, R. B. Rothman, T. E. Prisinzano, L. M. Bohn, An opioid agonist that does not induce μ-opioid receptor - Arrestin interactions or receptor internalization. Mol. Pharmacol. 71, 549-557 (2007).
13. S. M. DeWire, D. S. Yamashita, D. H. Rominger, G. Liu, C. L. Cowan, T. M. Graczyk, X.-T. Chen, P. M. Pitis, D. Gotchev, C. Yuan, M. Koblish, M. W. Lark, J. D. Violin, A G protein-biased ligand at the μ-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine. J. Pharmacol. Exp. Ther. 344, 708-717 (2013).
14. H. Zheng, J. Chu, Y. Qiu, H. H. Loh, P.-Y. Law, Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc. Natl. Acad. Sci. U.S.A. 105, 9421-9426 (2008).
15. H. Zheng, H. H. Loh, P.-Y. Law, β-Arrestin-dependent μ-opioid receptor-activated extracellular signal-regulated kinases (ERKs) translocate to nucleus in contrast to G protein-dependent ERK activation. Mol. Pharmacol. 73, 178-190 (2008).
16. H. Zheng, J. Chu, Y. Zhang, H. H. Loh, P.-Y. Law, Modulating μ-opioid receptor phosphorylation switches agonist-dependent signaling as reflected in PKC∈ activation and dendritic spine stability. J. Biol. Chem. 286, 12724-12733 (2011).
17. C. D. Harvey, A. G. Ehrhardt, C. Cellurale, H. Zhong, R. Yasuda, R. J. Davis, K. Svoboda, A genetically encoded fluorescent sensor of ERK activity. Proc. Natl. Acad. Sci. U.S.A. 105, 19264-19269 (2008).
18. J. D. Violin, J. Zhang, R. Y. Tsien, A. C. Newton, A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase C. J. Cell Biol. 161, 899-909 (2003).
19. T.-H. Lan, Q. Liu, C. Li, G. Wu, N. A. Lambert, Sensitive and high resolution localization and tracking of membrane proteins in live cells with BRET. Traffic 13, 1450-1456 (2012).
20. D. D. Jensen, C. B. Godfrey, C. Niklas, M. Canals, M. Kocan, D. P. Poole, J. E. Murphy, F. Alemi, G. S. Cottrell, C. Korbmacher, N. A. Lambert, N. W. Bunnett, C. U. Corvera, The bile acid receptor TGR5 does not interact with β-arrestins or traffic to endosomes but transmits sustained signals from plasma membrane rafts. J. Biol. Chem. 288, 22942-22960 (2013).
21. M. Freissmuth, S. Boehm, W. Beindl, P. Nickel, A. P. Izerman, M. Hohenegger, C. Nanoff, Suramin analogues as subtype-selective G protein inhibitors. Mol. Pharmacol. 49, 602-611 (1996).
22. T. Katada, M. Ui, Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc. Natl. Acad. Sci. U.S.A. 79, 3129-3133 (1982).
23. L. von Kleist, W. Stahlschmidt, H. Bulut, K. Gromova, D. Puchkov, M. J. Robertson, K. A. MacGregor, N. Tomilin, A. Pechstein, N. Chau, M. Chircop, J. Sakoff, J. P. von Kries, W. Saenger, H.-G. Kräusslich, O. Shupliakov, P. J. Robinson, A. McCluskey, V. Haucke, Role of the clathrin terminal domain in regulating coated pit dynamics revealed by small molecule inhibition. Cell 146, 471-484 (2011).
24. J. S. Herskovits, C. C. Burgess, R. A. Obar, R. B. Vallee, Effects of mutant rat dynamin on endocytosis. J. Cell Biol. 122, 565-578 (1993).
25. J. K. Scott, S.-F. Huang, B. P. Gangadhar, G. M. Samoriski, P. Clapp, R. A. Gross, R. Taussig, A. V. Smrcka, Evidence that a protein-protein interaction "hot spot on heterotrimeric G protein βγ subunits is used for recognition of a subclass of effectors. EMBO J. 20, 767-776 (2001).
26. W. J. Koch, B. E. Hawes, J. Inglese, L. M. Luttrell, R. J. Lefkowitz, Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G bg-mediated signaling. J. Biol. Chem. 269, 6193-6197 (1994).
27. D. Toullec, P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Boissin, E. Boursier, F. Loriolle, L. Duhamel, D. Charon, J. Kirilovsky, The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771-15781 (1991).
28. M. Gschwendt, S. Dieterich, J. Rennecke, W. Kittstein, H.-J. Mueller, F.-J. Johannes, Inhibition of protein kinase C m by various inhibitors. Inhibition from protein kinase c isoenzymes. FEBS Lett. 392, 77-80 (1996).
29. C. P. Bailey, S. Oldfield, J. Llorente, C. J. Caunt, A. G. Teschemacher, L. Roberts, C. A. McArdle, F. L. Smith, W. L. Dewey, E. Kelly, G. Henderson, Involvement of PKCα and G-protein-coupled receptor kinase 2 in agonist-selective desensitization of μ-opioid receptors in mature brain neurons. Br. J. Pharmacol. 158, 157-164 (2009).
30. M. Inoue, H. Ueda, Protein kinase C-mediated acute tolerance to peripheral μ-opioid analgesia in the bradykinin-nociception test in mice. J. Pharmacol. Exp. Ther. 293, 662-669 (2000).
31. F. L. Smith, B. H. Gabra, P. A. Smith, M. C. Redwood, W. L. Dewey, Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice. Pain 127, 129-139 (2007).
32. S. Illing, A. Mann, S. Schulz, Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C. Br. J. Pharmacol. 171, 1330-1340 (2014).
33. G. Martiny-Baron, M. G. Kazanietz, H. Mischak, P. M. Blumberg, G. Kochs, H. Hug, D. Marmé, C. Schächtele, Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. J. Biol. Chem. 268, 9194-9197 (1993).
34. J. A. Johnson, M. O. Gray, C.-H. Chen, D. Mochly-Rosen, A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J. Biol. Chem. 271, 24962-24966 (1996).
35. S. Schulz, D. Mayer, M. Pfeiffer, R. Stumm, T. Koch, V. Höllt, Morphine induces terminal μ-opioid receptor desensitization by sustained phosphorylation of serine- 375. EMBO J. 23, 3282-3289 (2004).
36. Y. Ohtani, T. Irie, K. Uekama, K. Fukunaga, J. Pitha, Differential effects of α-, β- and γ-cyclodextrins on human erythrocytes. Eur. J. Biochem. 186, 17-22 (1989).
37. A. W. Norman, R. A. Demel, B. de Kruyff, L. L. M. van Deenen, Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of filipin with cholesterol. J. Biol. Chem. 247, 1918-1929 (1972).
38. A. I. Basbaum, D. M. Bautista, G. Scherrer, D. Julius, Cellular and molecular mechanisms of pain. Cell 139, 267-284 (2009).
39. C. Doll, J. Konietzko, F. Pöll, T. Koch, V. Höllt, S. Schulz, Agonist-selective patterns of μ-opioid receptor phosphorylation revealed by phosphosite-specific antibodies. Br. J. Pharmacol. 164, 298-307 (2011).
40. K. A. DeFea, b-Arrestins as regulators of signal termination and transduction: How do they determine what to scaffold? Cell. Signal. 23, 621-629 (2011).
41. J. D. Robinson, J. A. Pitcher, G protein-coupled receptor kinase 2 (GRK2) is a Rho-activated scaffold protein for the ERK MAP kinase cascade. Cell. Signal. 25, 2831-2839 (2013).
42. P. Penela, C. Ribas, I. Aymerich, N. Eijkelkamp, O. Barreiro, C. Heijnen, A. Kavelaars, F. Sánchez-Madrid, F. Mayor, G protein-coupled receptor kinase 2 positively regulates epithelial cell migration. EMBO J. 27, 1206-1218 (2008).
43. H. Haberstock-Debic, M. Wein, M. Barrot, E. E. O. Colago, Z. Rahman, R. L. Neve, V. M. Pickel, E. J. Nestler, M. von Zastrow, A. L. Svingos, Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons. J. Neurosci. 23, 4324-4332 (2003).
44. H. Haberstock-Debic, K.-A. Kim, Y. J. Yu, M. von Zastrow, Morphine promotes rapid, arrestin-dependent endocytosis of μ-opioid receptors in striatal neurons. J. Neurosci. 25, 7847-7857 (2005).
45. C. P. Bailey, F. L. Smith, E. Kelly, W. L. Dewey, G. Henderson, How important is protein kinase C in μ-opioid receptor desensitization and morphine tolerance? Trends Pharmacol. Sci. 27, 558-565 (2006).
46. E. A. Johnson, S. Oldfield, E. Braksator, A. Gonzalez-Cuello, D. Couch, K. J. Hall, S. J. Mundell, C. P. Bailey, E. Kelly, G. Henderson, Agonist-selective mechanisms of μ-opioid receptor desensitization in human embryonic kidney 293 cells. Mol. Pharmacol. 70, 676-685 (2006).
47. X.-Y. Hua, A. Moore, S. Malkmus, S. F. Murray, N. Dean, T. L. Yaksh, M. Butler, Inhibition of spinal protein kinase Ca expression by an antisense oligonucleotide attenuates morphine infusion-induced tolerance. Neuroscience 113, 99-107 (2002).
48. F. L. Smith, A. B. Lohmann, W. L. Dewey, Involvement of phospholipid signal transduction pathways in morphine tolerance in mice. Br. J. Pharmacol. 128, 220-226 (1999).
49. Y. Qiu, W. Zhao, Y. Wang, J.-R. Xu, E. Huie, S. Jiang, Y.-H. Yan, H. H. Loh, H.-Z. Chen, P.-Y. Law, FK506-binding protein 12 modulates μ-opioid receptor phosphorylation and protein kinase Ce-dependent signaling by its direct interaction with the receptor. Mol. Pharmacol. 85, 37-49 (2014).
50. B. Feng, Z. Li, J. B. Wang, Protein kinase C-mediated phosphorylation of the μ-opioid receptor and its effects on receptor signaling. Mol. Pharmacol. 79, 768-775 (2011).
51. J. Chu, H. Zheng, Y. Zhang, H. H. Loh, P.-Y. Law, Agonist-dependent μ-opioid receptor signaling can lead to heterologous desensitization. Cell. Signal. 22, 684-696 (2010).
52. R. Winstel, S. Freund, C. Krasel, E. Hoppe, M. J. Lohse, Protein kinase cross-talk: Membrane targeting of the β-adrenergic receptor kinase by protein kinase C. Proc. Natl. Acad. Sci. U.S.A. 93, 2105-2109 (1996).
53. P. Huang, W. Xu, S.-I. Yoon, C. Chen, P. L.-G. Chong, E. M. Unterwald, L.-Y. Liu-Chen, Agonist treatment did not affect association of mu opioid receptors with lipid rafts and cholesterol reduction had opposite effects on the receptor-mediated signaling in rat brain and CHO cells. Brain Res. 1184, 46-56 (2007).
54. G. Gaibelet, C. Millot, C. Lebrun, S. Ravault, A. Saulière, A. André, B. Lagane, A. Lopez, Cholesterol content drives distinct pharmacological behaviours of μ-opioid receptor in different microdomains of the CHO plasma membrane. Mol. Membr. Biol. 25, 423-435 (2008).
55. L. Moulédous, S. Merker, J. Neasta, B. Roux, J.-M. Zajac, C. Mollereau, Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells. Biochem. Biophys. Res. Commun. 373, 80-84 (2008).
56. K. Suzuki, K. Ritchie, E. Kajikawa, T. Fujiwara, A. Kusumi, Rapid hop diffusion of a G protein-coupled receptor in the plasma membrane as revealed by single-molecule techniques. Biophys. J. 88, 3659-3680 (2005).
57. F. Daumas, N. Destainville, C. Millot, A. Lopez, D. Dean, L. Salomé, Confined diffusion without fences of a G protein-coupled receptor as revealed by single particle tracking. Biophys. J. 84, 356-366 (2003).
58. F. Daumas, N. Destainville, C. Millot, A. Lopez, D. Dean, L. Salomé, Interprotein interactions are responsible for the confined diffusion of a G-protein-coupled receptor at the cell surface. Biochem. Soc. Trans. 31, 1001-1005 (2003).
59. A. Saulière, G. Gaibelet, C. Millot, S. Mazères, A. Lopez, L. Salomé, Diffusion of the mu opioid receptor at the surface of human neuroblastoma SH-SY5Y cells is restricted to permeable domains. FEBS Lett. 580, 5227-5231 (2006).
60. A. Lopez, L. Salomé, Membrane functional organisation and dynamic of μ-opioid receptors. Cell. Mol. Life Sci. 66, 2093-2108 (2009).
61. D. D. Jensen, M. L. Halls, J. E. Murphy, M. Canals, F. Cattaruzza, D. P. Poole, T. Lieu, H.-W. Koon, C. Pothoulakis, N. W. Bunnett, Endothelin-converting enzyme 1 and β-arrestins exert spatiotemporal control of substance P-induced inflammatory signals. J. Biol. Chem. 289, 20283-20294 (2014).
62. F. Schmidlin, O. Déry, K. O. DeFea, L. Slice, S. Patierno, C. Sternini, E. F. Grady, N.W. Bunnett, Dynamin and Rab5a-dependent trafficking and signaling of the neurokinin 1 receptor. J. Biol. Chem. 276, 25427-25437 (2001).
63. M. L. Halls, D. P. Poole, A. M. Ellisdon, C. J. Nowell, M. Canals, in Methods in Molecular Biology (Springer, New York, 2015), vol. 1335, pp. 131-161.
64. U. Klein, G. Gimpl, F. Fahrenholz, Alteration of the myometrial plasma membrane cholesterol content with β-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 34, 13784-13793 (1995).
65. J. Schindelin, I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld, B. Schmid, J.-Y. Tinevez, D. J. White, V. Hartenstein, K. Eliceiri, P. Tomancak, A. Cardona, Fiji: An open-source platform for biological-image analysis. Nat. Methods 9, 676-682 (2012).
66. E. Kardash, J. Bandemer, E. Raz, Imaging protein activity in live embryos using fluorescence resonance energy transfer biosensors. Nat. Protoc. 6, 1835-1846 (2011).